Fidelity Investments’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Fidelity Investments's MXCT Position: Q1 2026 in Review
Fidelity Investments increased its MaxCyte (MXCT) stake by 32% in Q1 2026, buying an estimated $42.7K and bringing the position to 190,126 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.
Fidelity Investments first reported a position in MXCT in Q1 2022 and has held it in 17 quarters since. The position peaked at $14.4M in Q1 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Fidelity Investments held 190,126 shares of MaxCyte worth $134K as of Q1 2026.
- Fidelity Investments bought 45,740 MaxCyte shares in Q1 2026, an estimated $42.7K.
- MaxCyte made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3677 holding.
- Fidelity Investments first reported a position in MaxCyte in Q1 2022 and has held it in 17 quarters since.
- Fidelity Investments's MaxCyte position peaked at $14.4M in Q1 2024.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.